A detailed history of Adar1 Capital Management, LLC transactions in Evotec Se stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 9,400 shares of EVO stock, worth $43,052. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,400
Previous 7,700 22.08%
Holding current value
$43,052
Previous $60.3 Million 25.16%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.07 - $7.87 $6,919 - $13,379
1,700 Added 22.08%
9,400 $45.1 Million
Q1 2024

May 15, 2024

BUY
$6.89 - $11.4 $53,053 - $87,780
7,700 New
7,700 $60.3 Million

Others Institutions Holding EVO

About Evotec SE


  • Ticker EVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 353,904,992
  • Market Cap $1.62B
  • Description
  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...
More about EVO
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.